- Home
- VSTM vs CLPT Comparison
VSTM vs CLPT Comparison
Compare VSTM & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VSTM | CLPT |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.7M | 353.5M |
| IPO Year | 2011 | 2009 |
Fundamental Metrics
Financial Performance| Metric | VSTM | CLPT |
|---|---|---|
| Price | $6.50 | $11.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $16.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 2.2M | 527.6K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,914,000.00 | ★ $36,971,000.00 |
| Revenue This Year | $282.64 | $45.67 |
| Revenue Next Year | $72.25 | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 209.14 | 17.78 |
| 52 Week Low | $4.01 | $8.27 |
| 52 Week High | $11.25 | $30.10 |
Technical Indicators
Market Signals| Indicator | VSTM | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 62.33 | 58.48 |
| Support Level | $6.01 | $10.02 |
| Resistance Level | $6.79 | $11.74 |
| Average True Range (ATR) | 0.41 | 0.61 |
| MACD | 0.16 | 0.38 |
| Stochastic Oscillator | 82.93 | 83.27 |
Price Performance
Historical ComparisonAbout VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.